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Streszczenie
Cel pracy. Znany jest związek pomiędzy tłuszczową 
masą ciała a poziomem leptyny. Celem przedstawianej 
pracy jest poszukiwanie innych czynników wpływających 
na poziom leptyny jak wiek, stężenie insuliny, SHBG, 
hormony płciowe.
Materiał. 86 kobiet (średni wiek 47.0 ±14.3 lat, estradiol 
50.0±60.6 ng/l, FSH 52.4±42.9 IU/l; BMI 26.9±5.9) 
podzielono na trzy grupy według BMI. Grupę A 
stanowiło 39 kobiet o prawidłowej masie ciała (średni 
wiek 44.4±16.0 lat; estradiol 69.6±79.8 ng/l; FSH 50.4±47.7 
IU/l; BMI 22.9±1.3), grupę B 27 kobiet z nadwagą (średni 
wiek 55.0±6.4 lat; estradiol 25.1±17.2 ng/l; FSH 75.6±26.3 
IU/l; BMI 27.7±1.6) a grupę C 21 kobiet otyłych (średni 
wiek: 48.7±12.2 lat; estradiol 36.9±44.0 ng/l; FSH 42.3±36.6 
IU/l i BMI 34.6±4.9).
Metody. Standardowa ocena kliniczna i pomiar 
poziomu hormonów wykonywane były w warunkach 
podstawowych :LH, FSH, prolaktyna, estradiol, leptyna, 
IGF-I, hormon wzrostu, IGFBP-3, insulina, DHEAS, 
SHBG, testosteron. Poziom hormonów oceniano metodą 
RIA. W analizie statystycznej zastosowano testy Shapiro 
– Wilk, Manna – Whitneya oraz test korelacji rang 
Spearmana.
Wyniki. Biorąc pod uwagę wszystkie badane kobiety 
(n=86) stwierdzono korelację poziomu leptyny z wie-
kiem (r=0.32; p<0.02), masą ciała (r=0.60; p<0.001), BMI 
(r=0.71; p<0.001) a także odwrotną korelację ze stężeniem 
estradiolu (r=-0.21; p<0.05), IGF-I (r=-0.24; p<0.05), SHBG 
(r=-0.34; p<0.01) i DHEAS (r=-0.30; p<0.01). 
Jedynie w grupie B stosunek stężenia leptyny do wieku 
zależał od BMI (r=0.40; p<0.05). W grupie tej wykazano 
związek stężenia leptyny ze stężeniem DHEAS (r=-0.40; 
p<0.05) i PRL (r=0.51; p<0.05). W grupie C wykazano 
zależność poziomu leptyny od SHBG (r=-0.56; p<0.02) 
oraz związek stężenia insuliny i leptyny (r=0.48; p<0.05).
Zależność masy ciała, BMI i wieku występuje w całej 
grupie 86 badanych kobiet (r=0.30; p<0.002: r=0.36; 
p<0.001 odp.). Zależność ta zanika w poszczególnych 
grupach lub staje się korelacją odwrotną. 
Analizując zależność wieku i poziomu leptyny u 
wszystkich kobiet stwierdzono prostą korelację między 
tymi parametrami dla kobiet przed menopauzą (n=29; 
r=0.43; p<0.02) i odwrotną u kobiet po menopauzie (n=38; 
r=-0.32; p<0.05).
Poziom leptyny w surowicy krwi był najwyższy (p< 
0.001) w grupie C (23.2±10.4 µg/l) a najniższy w grupie 
A (8.9±4.1 µg/l). To koresponduje z różnicami średnich 
wskaźników masy ciała w badanych grupach.
Analiza regresji wieloczynnikowej ujawniła, że 
wskaźnik masy ciała odpowiada w 31% (p<0.01) 
a poziom SHBG w surowicy w 17,7% (p<0.02) za 
zmienność poziomu leptyny w surowicy u wszystkich 
badanych kobiet. W grupie A masa ciała i wiek łącznie 
odpowiadały za 61% (p<0.01) oraz estradiol za 44 % 
(p,0.02) zmienności stężeń leptyny w surowicy. W 
grupie B insulina odpowiadała za 39% (p<0.05) a łącznie 
z testosteronem za 46% (p< 0.05) zmienności stężeń 
leptyny w surowicy. W grupie kobiet otyłych żaden 
z badanych parametrów w sposób istotny statystycznie 
nie oddziaływał na zmienność stężeń leptyny 
w surowicy. 
Wnioski. Wyniki prezentowanej pracy potwierdzają 
silny wpływ masy ciała na stężenie leptyny we krwi. 
Jednak także insulina, SHBG, hormony płciowe podobnie 
jak wiek mają wpływ na stężenie leptyny w surowicy w 
określonych grupach kobiet. 
(Endokrynol Pol 2005; 5(56): 883-890)
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Abstract
Aim. As the link between body fat and leptin is well 
known, the aim of the study was to seek for secondary 
regulators of plasma leptin level.
Patients. 86 women (mean: age 47.0±14.3 years; estradiol 
50.0±60.6 ng/l; FSH 52.4±42.9 IU/l; BMI 26.9±5.9) divided 
into three groups according to their BMI. Group A: 
39 normal weight women (mean: age 44.4±16.0 years; 
estradiol 69.6±79.8 ng/l; FSH 50.4±47.7 IU/l; BMI 
22.9±1.3). Group B: 27 overweighted women (mean: age 
55.0±6.4 years; estradiol 25.1±17.2 ng/l; FSH 75.6±26.3 
IU/l; BMI 27.7±1.6). Group C: 21 obese women with 
mean: age 48.7±12.2 years; estradiol 36.9±44.0 ng/l; FSH 
42.3±36.6 IU/l and BMI 34.6±4.9. 
Methods. Standard clinical evaluation and hormone 
evaluation (LH, FSH, prolactin, estradiol, leptin, insulin-
like growth factor-I (IGF-I), human growth hormone 
(hGH), insulin-like growth factor binding protein-3 
(IGFBP-3), insulin, dihydroepiandrosterone sulphate 
(DHEAS), sex hormone binding globin (SHBG) and 
testosterone were done in basic condition which levels of 
were measured by RIA kits. 
Statistical analysis. Shapiro-Wilk test, Mann-Whitney-
Wilcoxon u test, Spearman rank correlation coefficient 
and stepwise multiple regression: p values of 0.05 or less 
were considered as significant.
Results. Taking all women into account (n=86) the plasma 
leptin level correlated directly with age (r=0.32; p<0.02), 
body mass (r=0.60; p<0.001), BMI (r=0.71; p<0.001) as 
well as inversely with estradiol (r=-0.21; p<0.05), IGF-I 
(r=-0.24; p<0.05), SHBG (r=-0.34; p<0.01) and DHEAS 
(r=-0.30; p<0.01). However only in the group B leptin/
age relation remained (r=0.40; p<0.05) after the division 
according to BMI. In the group B the leptin /DHEAS (r=-
0.40; p<0.05) and leptin/PRL (r=0.51; p<0.05) links were 
also present. In the group C the leptin/SHGB relation (r=-
0.56; p<0.02) only remained and an association between 
insulin and leptin was found (r=0.48; p<0.05). The body 
mass and BMI relation to age were again present only 
in all 86 women (r=0.30; p<0.002: r=0.36; p<0.001 resp.). 
Having split the women into groups, these links either 
disappeared or became inverse (rC=-0.39; p<0.05). Taking 
into consideration age/leptin relation in all women, the 
division according to the menopausal status revealed the 
direct relation in premenopausal women (n=29; r=0.43; 
p<0.02) and a reverse one in postmenopausal women 
(n=38; r=-0.32; p<0.05)
The plasma leptin level was the highest (p<0.001) in 
group C (23.2±10.4 µg/l) and the lowest was found in 
the group A (8.9±4.1 µg/l). That corresponded with the 
differences in mean body mass index and mean body 
mass.
The stepwise multiple regression revealed that body 
mass index accounted for 31% (p<0.001) and plasma 
SHBG level accounted for 17.7% (p<0.02) of plasma leptin 
variance in all women. In the group A body mass and age 
together accounted for 61% (p<0.01) and estradiol alone 
accounted for 44% (p<0.02) of plasma leptin variance. In 
the group B insulin alone accounted for 39% (p<0.05) and 
together with testosterone accounted for 46% (p<0.05) 
of plasma leptin variance. Finally in obese women none 
of the evaluated parameters significantly accounted for 
leptin variance.
Conclusion. The results presented in this paper confirmed 
the strong influence of body fat mass on serum leptin 
concentration. However insulin, SHBG, sex steroids as 
well as age may also exert secondary influence on plasma 
leptin level in certain groups of women.
(Pol J Endocrinol 2005; 6(56): 883-890)
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Introduction
Leptin is a 16kD peptide hormone encoded by OB 
gene located at the 7q31.3. It is synthesised mainly 
by adipocytes and secreted in a pulsatile manner 
with mean periodicity of roughly 30 minutes 
(6,16,29). Diurnal changes of serum leptin level 
have been reported with highest levels between 
midnight and early morning and lowest in early 
afternoon (21). 
Body mass index (BMI) and fat cell volume 
strongly, directly correlate with leptin secretion 
rate, although there is a considerable interindividual 
variability in OB gene expression and serum leptin 
concentration at each BMI level (14). Increase in body 
fat mass results in elevation of plasma leptin concen-
tration (17). Leptin secretion rate from adipose tissue 
correlates in turn with plasma leptin concentration 
(15). Not only BMI which reflects body fat mass 
but also the pattern of body fat distribution relates 
independently to circulating leptin level (28). Trunk 
fat mass explains more of the variance in circulating 
leptin concentration than leg fat, suggesting that 
propensity to leptin resistance may be increased in 
women with central adiposity (25). 
The leptin level variability among subjects with 
the same fat stores suggests that these stores are 
unlikely to be the only factor that regulates leptin 
concentration (41). Geisthovel et al. suggested 
the insulin as the second (beside body fat mass) 
leptin concentration regulating factor (30). Serum 
leptin level is higher in normally menstruating 
females than in males (2,22,26). Gender diffe-
rences in plasma leptin levels have been ascribed 
to a variable degree in amount of body fat as well 
as to differences in body fat distribution pattern 
(20,26). Independent of body fat mass and distri-
bution in turn, no differences in leptin concentra-
tion between females and males were observed 
(20). However a possible role of sex hormones 
cannot be rule out (19). There are conflicting data 
in regard to the role of sex steroids in regulation 
of serum leptin level. Puberty is associated with 
serum leptin concentration increase regardless the 
children body mass (26). Leptin was found in folli-
cular fluid and its administration in vitro increases 
the number of maturing oocytes in ovarian tissue. 
It is also thought as a link between energy stores 
and reproductive axis passing the message about 
body nutritional status permitting the reproduc-
tion to go forward if sufficient metabolic resources 
are available and blocking it if resources are low or 
metabolic system is stressed. On the other hand the 
estrogen administration either in form of ethinyl 
derivatives or native 17-β estradiol was not able to 
increase the serum leptin level (19). Roemmich et al. 
showed by means of stepwise multiple regression 
that combined influence of estradiol, free testoste-
rone and subcutaneous fat depot was responsible 
for 74% of leptin level changes (31). Janssen et al. 
suggested a role of DHEAS in gender specific diffe-
rences in leptin levels (37).
The data on role of age in regulation of leptin 
plasma level is also contradictory. Ryan and Nicklas 
found the increase in intraabdominal adipose tissue 
and subcutaneous fat with age while Kumar et 
al. observed in rats the age related increment in 
adiposity, leptin mRNA and serum leptin level 
(38,39). De Silva et al. in a cohort of 359 women and 
Sumner et al. in a group od 101 African American 
found no link between serum leptin level and age 
whereas Jorgensen et al. observed higher leptin 
levels in elderly people (3,5,23). Ostlund et al. found 
an inverse relation between age and leptin which 
plasma level was reduced by 53% in subjects over 
age of 60 years (41). Sinha and Caro found a leptin/
age correlation (r=0.26; p<0.001) in a group of 275 
women (20). Koistinen et al. suggested in turn no 
apparent effect of aging on serum leptin level (40).
Aim of the study
Therefore it seemed interesting to seek for secondary 
regulators of plasma leptin level such as age, sex 
steroids growth hormone axis and insulin during 
consecutive stages of female life.
Patients
86 women were divided according to their BMI 
into three groups. 38 normal weight women (mean: 
age 44.4±16.0 years; estradiol 69.6±79.8 ng/l; FSH 
50.4±47.7 IU/l; BMI 22.9±1.3) formed group A. 
Group B consisted of 27 overweighted women 
(mean: age 55.0±6.4 years; estradiol 25.1±17.2 
ng/l; FSH 75.6±26.3 IU/l; BMI 27.7±1.6). Group C 
embraced 21 obese women with mean: age 48.7±12.2 
years; estradiol 36.9±44.0 ng/l; FSH 42.3±36.6 IU/l; 
BMI 34.6±4.9.
Methods
Standard clinical evaluation (general and gynaeco-
logical evaluation) was carried out in each woman. 
Body mass index was calculated as body mass (kg) 
divided by height squared (m2).
Hormonal assessment (routine - FSH, testoste-
rone, estradiol as well as leptin, insulin-like growth 
factor-I (IGF-I), human growth hormone (hGH), 
insulin-like growth factor binding protein-3 (IGFBP-
3), insulin, sex hormone binding globulin (SHBG), 
dihydroepiandrosterone sulphate (DHEAS) was 
done in basic conditions (blood for serum collection 
was obtained at 800 am after12 hours of fasting, none 
of the patients was on any medication which may 
change the levels of evaluated parameters) in each 
patient. Basic levels of hormones were measured by 
RIA kits in plasma which was deeply (-20oC) frozen 
prior to the procedure. 
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Statistical analysis
Due to lack of normal distribution of data 
(confirmed by W.Shapiro-Wilk test) nonparame-
tric tests were used. To evaluate the significance of 
mean values differences Mann-Whitney U test was 
applied and mutual relations between parameters 
were estimated by means of Spearman rang correla-
tion coefficient as well as stepwise multiple regres-
sion; p values of 0.05 or less were considered as 
significant.
Results
The mean age of evaluated women (n=86) was 
47.0±14.3 years. Mean body mass was 70.7±16.6 kg 
and mean BMI was 26.9±5.9. Mean plasma leptin 
level was 15.8±9.5 ng/ml The clinical characteristics 
of the total group is shown in table 1.
Women with normal range of BMI (20-25) (group 
A) were the youngest (44.4±16.0 years) compared to 
overweighted women from group B (55.0±6.4 years) 
and to obese ones (48.7±12.2 years; NS). Needless to 
say that mean body mass and BMI were the lowest 
in group A (61.4±5.2 kg; 22.9±1.3 resp.; p<0.001) and 
the highest in group C (89.9±15.8 kg; 34.6±4.9 resp.). 
Mean leptin level mimic the differences in mean 
BMI and body mass. The highest was in group C 
(23.2±6.8 ng/ml) and the lowest (p<0.001) in group 
A (8.9±4.1ng/ml). Mean FSH level was the highest 
in the oldest group B (75.6±26.3U/l) Gonadotropin 
level was the lowest in the group C (42.3±36.6 U/l). 
Mean estradiol levels was the highest in group C 
and the lowest in group B however due to large 
standard deviations the differences did not reach 
statistical significance. Despite the differences in 
mean BMI, the mean plasma insulin levels were 
similar. The highest mean testosterone level was 
found in obese women (group C – 0.54±0.19 ng/
ml) and the lowest in group A (0.41±0.18 ng/ml; 
p<0.01).
The highest mean plasma hGH and IGF-I levels 
were found in the youngest group A (5.3±8.1 ng/
ml; 247.0±104.4 ng/ml resp.; p<0.01) and the lowest 
in the oldest women (group B) (1.6±1.7 ng/ml; 
185.0±56.7 ng/ml resp.). Mean SHBG level was the 
highest in group A (74.1±59.1 ng/ml) and the lowest 
in the obese group C (39.4±19.5 ng/ml)(table 2). 
There were no statistically significant diffe-
rences in mean DHEAS and IGFBP-3 levels between 
groups (table 2).
In all women leptin level correlated to body 
mass and BMI (r=0.60; r=0.71; p<0.001 resp.) as well 
as with age (r=0.32; p<0.02). Body mass and BMI 
were related to age in the same women (r=0.30; 
p<0.002; r=0.36; p<0.001 resp.). Age was inversely 
linked to estradiol (r=-0.57; p<0.001), IGF-I (r=-0.60; 
p<0.001) and DHEAS (r=-0.51; p<0.001). 
Plasma leptin correlated inversely to estradiol 
(r=-0.21; p<0.05), IGF-I (r=-0.24; p<0.05), SHBG (r=-
0.34; p<0.02) and DHEAS (r=-0.30; p<0.02). BMI in 
turn was related to plasma estradiol (r=-0.25; p<0.02), 
IGF-I (r=-0.32; p<0.002) and SHBG (r=-0.34; p<0.005). 
Estradiol in turn, was associated with IGF-I (r=-0.37; 
p<0.001) and with FSH (r=-0.57; p<0.001) levels.
In group of women with normal weight (A) 
the relations between leptin and other evaluated 
parameters disappeared as well as those between 
body mass and BMI which were present in all 
women. In the group the estradiol/age, DHEAS/
age and IGF-I/age relations were still present 
(r=-0.58; p<0.001; r=-0.46; p<0.01; r=-0.71; p<0.001 
resp.). The estradiol/IGF-I and estradiol/FSH links 
were also present (r=0.51; r=-0.70; p<0.001 resp.).
In overweighted women (group B) despite the 
lack of BMI/age and body mass/age as well as 
leptin/BMI and leptin/body mass links, the leptin/
age relation was present (r=0.40; p<0.05). In the 
group B leptin was also related to DHEAS (r=-0.40; 
p<0.05) and to PRL (r=0.51; p<0.05). DHEAS was 
linked to age(r=-0.67; p<0.01) and estradiol (r=0.51; 
p<0.02) in group B. The age/estradiol, age/IGF-I 
Table 1. The clinical characteristics of normal weighted (group A) and overweighted (group B) patients as well as obese 
women (group C).
 Group
Parameter
A
n=38
B
n=27
C
n=21
P
Age (years)
(range)
44.4 ± 16.0
(19– 48)
 55.0 ± 6.4
(50-54.0)
 48.7 ± 12.2
(25.0 – 60.0)
NS
Body mass (kg)
(range)
61.4 ± 5.2
(43 - 78)
71.8 ± 12.4
(55 − 101.9)
89.9 ± 15.8
(57-130.2)
A/C<0.001; NS
BMI
(range)
22.9 ± 1.3
(16.6-24.3)
28.5 ± 1.4
(25.2 – 29.9)
34.6 ± 4.9
(30.1 – 39.0)
<0.01
FSH (IU/l)
(range)
55.2 ± 22.4
(2.9 - 79.8)
75.6 ± 23.6
(32.1-143.5)
42.3 ± 36.6
(33.1 – 150)
B/C<0.05; NS
Testosterone (ug/l)
(range)
0.41 ± 0.18
(0.1 – 0.9)
0.48 ± 0.15
(0.3 – 0.8)
0.54 ± 0.19
(0.1 – 0.8)
A/C<0.01; NS
Estradiol (ng/l)
(range)
 20.8± 24.6 
 (5.0 - 284)
18.6 ± 23.7
(9.9 – 47.7)
 89.1 ± 74.9
 (3.6- 249)
NS
Czynniki regulujące poziom leptyny u kobiet Milewicz T.
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and estradiol/IGF-I links vanished in the group B.
In obese women (group C) body mass age 
relation became inverse (r=-0.39; p<0.05). Again 
the leptin/ body mass and leptin/BMI as well as 
leptin/age links were not found. However leptin 
correlated with SHBG (r=-0.56; p<0.02) and insulin 
(r-0.48; p<0.05) levels. Age was related to IGF-I (r=-
0.60; p<0.001) and estradiol (r=-0.52; p<0.01) plasma 
levels.
The results of stepwise multiple regression 
showed that body mass index accounted for 31% 
(r2=0.31; p<0.001) and SHBG for 17.7% (r2=0.177; 
p<0.02) of plasma leptin variance in all women. 
In group A body mass alone accounted for 34% 
(p<0.05) whereas together with age accounted for 
61% (p<0.01) of plasma leptin variance. In group 
B insulin alone accounted for 39% and together 
with testosterone for 46 % (p<0.05) of plasma leptin 
variance. In obese women (group C) none of the 
evaluated parameters was included in a signifi-
cant way into the mathematical model of stepwise 
multiple regression. 
The leptin increases with age in the youngest 
group (n=29)(r=0.43; p<0.02). There is no link 
between leptin and age in early menopausal 
women (r=0.11; NS). In post menopausal women 
the leptin/age relation became again significant but 
in an inverse way (r=-0.32; p<0.05).
Discussion
Our results confirmed once again a well known 
direct correlation between body fat mass reflected 
by BMI and serum leptin level, which is a hormonal 
product of the adipose tissue and mediates the 
satiety signal from peripheral fat stores to the 
central nervous system (2,3,16,20,25-27,29). The 
highest mean plasma leptin level was found in 
women with the greatest fat stores (BMI>30; group 
C). However the statistically significant plasma 
leptin with BMI and body mass/leptin relations 
disappeared when the BMI range became shorter 
(after the division for groups A, B, C). That astoni-
shing could result from either narrower BMI values 
range in each of groups than in the total material 
or the necessity of nonparametric statistics use due 
the non-gausian distribution of data. The correla-
tion coefficients and p values were close to signi-
ficance (r=0.29-0.31; p=0.06-0.08) only in the group 
A, whereas in other groups the coefficients were 
low (r=0.04-0.1; p=0.6-0.8). Moreover body mass 
index is an easy but not exact tool to measure body 
fat stores and that may also explain that disappe-
arance of the known, leptin/BMI relation. Unfor-
tunately we did not measure the actual fat stores 
of the patients. Moller et al. in group of 70 healthy 
subjects, observed lack of correlation (r=0.2; p=0.4) 
between leptin and relative body fat content in 
middle aged (53.0±1.0 years) and elderly (70.0±1.0 
years) males and females, whereas in young 
(25.0±1.0 years) normally menstruating (i.e. normo-
estrogenic) women this correlation was very strong 
(r=0.71; p=0.009) (18). That disrupted link in those 
groups may contribute to the obesity occurring with 
age and also to the observed in postmenopausal 
women visceral fat mass increase what is reflected 
by the gain in WHR (18,27). 
Age, sex hormones, insulin and SHBG may 
affect plasma leptin level (1,3,5,12,23,25). That 
was also confirmed by stepwise multiple regres-
sion analysis (19). In our study the application of 
stepwise multiple regression analysis revealed that 
BMI, age, insulin, testosterone, estradiol and SHBG 
accounted for certain percentage of plasma leptin 
variance in investigated groups.
There is much controversy upon age influence 
on serum leptin concentration. Normally menstru-
ating women show higher leptin level than men 
and postmenopausal ones (23,26). That level in both 
normally weighted and obese women may up to 3 
times higher than in men (41). Sumnar et al. in a 
cohort of 101 African Americans with nearly twice 
Table 2. The mean plasma levels of leptin, insulin, DHEAS, SHBG and somatropic axis in normal weighted patients 
(group A) and overweighted (group B) patients as well as obese women (group C).
 Group
Parameter
A
n=38
B
n=27
C
n=21
p
leptin (µg/l)
(range)
8.9± 4.1
(2.6-28.5)
18.0± 9.0
 (5.4-32.4)
 23.2 ± 6.8
(3.0 - 36.8)
A/C<0.001;NS 
IGF-I (µg/l)
(range)
247.0± 104.4
(116.1-688)
185.0± 56.7
 (83.8-264.3)
 206.3 ± 56.5
(71.3 – 346.1)
A/B < 0.01;NS
hGH (µg/l)
(range)
5.3± 8.1
(0.1-28.5)
1.6± 1.7
(0.2-6.8)
1.9 ± 1.7
(0.1 - 7.3)
A/B < 0.01; NS
IGFBP-3 (µg/l)
(range)
4.0± 1.3
(2.0 – 7.8)
3.4 ± 1.1
(2.0 - 5.5)
3.9± 1.2
(1.1 - 5.7)
NS
insulin (IU/l)
(range)
15.1± 6.7
(4.1 - 27.4)
13.4 ± 4.4
(4.6 - 21.2)
13,0± 8.7
(2.9 - 45.3)
NS
DHEAS (µg/l)
(range)
194.2± 103.0
(5.5 - 352.5)
108.3 ± 59.4
(33.9 - 326.9)
149.2 ± 81.3
(31.7 - 340.0)
NS 
SHBG (µg/l)
(range)
74.1±59.1
(17.9-193.9)
40.8±62.2
(7.6—172.1)
39.4±19.5
(8.9-112.9)
A/C<0.05; NS
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as high mean serum leptin level as observed in our 
groups showed hardly any differences in mean 
serum leptin levels between pre- and postmeno-
pausal women (33.9±17.3 ng/ml; 31.4±22.3 ng/ml 
resp.) (23). De Silva et al., Taylor et al. as well as 
Ahren et al. found no relation between leptin level 
and age in women (1,3,25). Castracane et al. found 
no differences in mean serum leptin level between 
pre- and postmenopausal women receiving either 
estrogen-progestin formulations (oral contracep-
tives or hormonal replacement therapy resp.) (2). 
Contrary to that, studies on animals showed the 
increase of serum leptin and leptin mRNA concen-
trations with age and suggest the development of 
leptin resistancy in ageing animals (13). Similar data 
regards healthy adults. Singha and Caro in a group 
of 275 patients observed a direct correlation between 
age and serum leptin level (r=0.26; p<0.001) (20). In 
our study the age/leptin relation in 86 patients was 
also found (r=0.32; p<0.002). It was also observed 
in overweighted women (group B)(r=0.40; p<0.05), 
whereas vanished both in women with normal 
weight and in obese ones. Ostlund et al. found an 
inverse link between age and plasma leptin level 
in postmenopausal women over 60 years of age, 
but the correlation coefficient was weaker (r=-
0.175; p=0.012)(41). In younger subjects (mean age 
29 years in normal-weight group and 37 years in 
obese group) Considine et al found that age did not 
have an independent relation to plasma leptin after 
adjustment for body fat (42). In our study, according 
to Ostlund et al. suggestion we introduced another 
division of the material – according to age. The age/
leptin relation was found as a direct one in preme-
nopausal women (r=0.43; p<0.02) and as an inverse 
in postmenopausal ones (r=-0.32; p<0.05). The mean 
age of our postmenopausal group was similar to 
that in Ostlund’s study. Another explanation of 
the leptin/age link may be taken from the presence 
of the age related body mass and BMI increase 
observed in total material. 
Sztefko et al. found significantly lower mean 
leptin level in young women with hypothalamic 
amenorrhoea compared with normally menstru-
ating women and postmenopausal one and 
Jorgensen et al. in turn observed higher leptin levels 
in elderly people (5,24). Koistinen et al. observed a 
significant difference in mean leptin level between 
males of 30 years of age and those with mean age 
around 75 years. The observed age-related increase 
in mean plasma leptin level could also be explained 
by the influence of pituitary and gonadal hormones 
as well as insulin (40). 
Pituitary as well as gonadal hormones may also 
affect the plasma leptin level. Similar to age/leptin 
relation, there is much controversy on that effect. 
Low concentration of leptin in vitro stimulate 
independently hypothalamic LHRH release and 
LH, FSH release from pituitary. That action is to 
be mediated via neuropeptide Y in central nervous 
system. (26). The patterns of LH and leptin release 
are similar. Leptin, LH and estradiol show parallel 
type of fluctuactions during menstrual cycle (26). 
Krassas et al. observed an inverse relation (r=-
0.60) between leptin and gonadotropins levels in 
women with polycystic ovary syndrome (PCOS), 
although due to small number (n=8) of subjects 
it was not statistically significant (7). Krzyża-
nowska et al. showed in a group of 11 obese 
women the inverse relation between gonadotro-
pins and serum leptin levels (rLH=-0.70; p=0.03; 
rFSH=-0.65; p=0.05) which disappeared in normal-
weighted subjects (12). Contrary to that, Teirmaa et 
al. and Sztefko et.al. observed (in cohorts of 8 and 
61 resp.) a direct relation between serum LH and 
leptin levels (rT=0.40; p<0.01; rSz=0.70; p<0.01 resp.) 
(24,26). Śmiarowska et al. in a group of 7 women 
with anorexia nervosa also found a direct correla-
tion between LH and serum leptin (r=0.82; p=0.04), 
which vanished in normally weighted, normally 
menstruating women (11). Kulik-Rechtberger and 
Rechtberger found links between leptin and FSH 
(r=0.23; p<0.01) as well as leptin and estradiol 
(r=0.33; p<0.001) in pubertal girls (43). In our study, 
the stepwise regression analysis revealed that FSH 
together with body mass and age accounted for 74% 
of plasma leptin variance in the group A. In all 86 
women we observed an inverse relation between 
leptin and estradiol (r=-0.21; p<0.05).
Adipocytes’ leptin mRNA was reduced by 60% 
after adding of DHEAS to the culture (119,129). In 
our previous study we found a link between serum 
leptin and DHEAS levels in young women with low 
estradiol level (r=-0.32; p<0.05)(33). Janssen et al. 
also found an inverse relation between DHEAS and 
leptin (37). In our present study we also found an 
inverse relation between plasma leptin and DHEAS 
levels in all women and that relation was also 
present in overweighted women. 
Jorgensen found that hGH increases, indepen-
dently of body composition, the resting metabolic 
rate, which in turn correlates strongly (r=0.56; 
p<0.001) with leptin (5). In our study we observed a 
reverse link between plasma leptin and IGF-I levels 
(r=-0.24; p<0.05).
Paolisso et al. found in a cohort of 39 females a 
statistically significant association between estradiol 
and leptin plasma levels (r=0.53) and an inverse 
link (r=-0.43) between testosterone and leptin in 
males (19). Krzyżanowska et al. observed a direct 
estradiol/leptin relation (r=0.67; p=0.03) in 11 obese 
women and that link became the inverse one in 16 
women with normal BMI range (r=-0.67; p=0.03) 
(11). A similar type of estradiol/leptin association 
was found in 16 normally menstruating women by 
Śmiarowska et al. and Leenen et al. observed the 
relation between abdominal obesity and total testo-
sterone level in women (12,20). 
Czynniki regulujące poziom leptyny u kobiet Milewicz T.
P
R
A
C
E
  
O
R
Y
G
IN
A
L
N
E
888
P
R
A
C
E
  
O
R
Y
G
IN
A
L
N
E
Endokrynologia Polska / Polish Journal of Endocrinology  2005;  6 (56)
889
Vettor et al. and Perry et al. found a link between 
plasma leptin and testosterone levels in 65 and 94 
women. Correlation coefficient varied from 0.38 
to 0.50(131,132). Urbański and Pau showed even 
a higher correlation coefficient in animal model 
(r=0.67)(36). In our study testosterone together with 
insulin accounted for 46% of plama leptin varince in 
women with BMI ranging from 25 to30. 
Insulin also plays a role in regulation of leptin 
secretion and its serum level. Short lasting (2-4 hours) 
hyperinsulinemia seems not to exert any influence 
on leptin level, whereas long lasting one (72 hours) 
exerts a stimulatory effect on leptin secretion (4,7). 
Leptin receptors were found in pancreatic β-cells 
and insulin may also exert its action on carbohydrate 
metabolism by activation of adrenergic α-receptors 
in β-cells. Leptin infusion markedly decreased both 
plasma insulin and glucose levels not only by the 
mentioned mechanism but also by resulting partly 
of them increase in insulin sensitivity (20). Insulin 
and tumor necrosis factor-α (TNF-α) release leptin 
of its pool in adipose tissue (16). The persistence of 
high insulin and TNF-α levels are common finding 
in postmenopausal women (22). Ob gene expression 
is modulated by insulin as well as by glucocorticoids 
and catecholamines (20). Rosenbaum showed that in 
males but not in pre- and postmenopausal women 
fasting insulin levels correlated significantly with 
leptin levels. Singha and Caro observed in a group of 
275 patients a similar leptin/insulin relation (r=0.57) 
in a group of 275 subjects (20). Baumgartner et al. 
revealed by mean of stepwise multiple regression, in 
a group of 56 postmenopausal women, the indepen-
dent of body fat mass, insulin role in regulation of 
leptin plasma concentration (32). Van den Saffele 
et al. applied multiple linear regression and found 
that BMI, age and insulin are significant indepen-
dent correlates of serum leptin in men (44).The leptin 
infusion leads to the decrease of glucose and insulin 
levels (20). In our study we observed a direct link 
between insulin and leptin in obese women (r=0.48; 
p<0.05) and insulin alone accounted for 39% of 
plasma leptin variance in women with overweight.
Van Rossum et al. applied stepwise regression 
analysis and found that plasma SHBG was one of 
the independent predictors of the relative change in 
leptin concentration and together with body mass 
and intravisceral fat volume accounted for 48% of 
plasma leptin variance (45). Relative changes in 
leptin with weight loss in 54 obese women (mean 
age 60±6 years old) correlated with SHBG (r=0.38; 
p<0.01). Obese postmenopusal women with lower 
initial SHBG level and more visceral obesity had a 
greater decrease in leptin with weight loss.
Our results showed that in certain groups of 
women age, insulin, SHBG, and sex steroids may 
influence the plasma leptin level. This influence 
seems to be secondary to fat stores impact on the 
leptin level.
Conclusion
The results presented in this paper confirmed the 
strong influence of body fat mass on serum leptin 
concentration. However insulin, SHBG, sex steroids 
as well as age may also exert secondary influence on 
plasma leptin level.
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